Stock 688278 XIAMEN AMOYTOP BIOTECH CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Xiamen Amoytop Biotech Co., Ltd.

Equities

688278

CNE100003RT3

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-22 pm EDT 		5-day change 1st Jan Change
59.5 CNY -7.99% Intraday chart for Xiamen Amoytop Biotech Co., Ltd. -10.12% +13.66%
Apr. 22 Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 18 China Stocks Advance Over Positive Economic Data; Amoytop Biotech Rises 6% MT

Business Summary

XIAMEN AMOYTOP BIOTECH CO., LTD is a China-based company mainly engaged in the biopharmaceutical business, including the research, development, manufacture and sales of recombinant proteins and their long-acting modified drugs. The Company's main research and development direction is immune-related cytokine drugs, focusing on systemic immune solutions based on cytokine drugs, and its products mainly include Peginterferon alfa-2b Injection, rhGM-CSF (Recombinant Human Granulocyte/Macrophage Colony-Stimulating Factor for Injection), rHuG-CSF (Recombinant Human Granulocyte-Colony Stimulating Factor for Injection) and Recombinant Human Interleukin-11 for Injection. The Company distributes its products within domestic market and to overseas markets.

Number of employees: 1,960

Sales per Business

CNY in Million2022Weight2023Weight Delta
Recombinant Protein Drugs, Health Consulting and Medical Services
100.0 %
1,517 100.0 % 2,100 100.0 % +38.46%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
99.8 %
1,513 99.7 % 2,089 99.8 % +38.07%
Overseas
0.2 %
4 0.3 % 4 0.2 % -3.63%

Managers

Managers TitleAgeSince
Li Sun CEO
 Chief Executive Officer 58 13-04-30
Yi Ling Yang DFI
 Director of Finance/CFO 49 97-06-30
Shi Yuan Wang CTO
 Chief Tech/Sci/R&D Officer 51 00-08-31
Li Ping Lai BRD
 Director/Board Member 53 96-08-06
Zhong Hong Zuo BRD
 Director/Board Member 60 18-07-31
Pei Yu Liu IRC
 Investor Relations Contact 38 19-11-30
Jie Hua Zheng PRN
 Corporate Officer/Principal 44 96-08-06
Fang He Chen PRN
 Corporate Officer/Principal 59 96-08-06
Ping Zou PRN
 Corporate Officer/Principal 59 98-11-30
Mei Hua Yang PRN
 Corporate Officer/Principal 52 98-11-30

Members of the board

Members of the board TitleAgeSince
Li Na Jia BRD
 Director/Board Member 57 18-07-31
Chun Lan BRD
 Director/Board Member 58 00-03-31
Li Sun CEO
 Chief Executive Officer 58 13-04-30
Ying Yang BRD
 Director/Board Member 61 18-07-31
Zhong Hong Zuo BRD
 Director/Board Member 60 18-07-31
Qing Xi Chen BRD
 Director/Board Member 65 18-07-31
Chao Dong Li BRD
 Director/Board Member 60 18-07-31
Li Ping Lai BRD
 Director/Board Member 53 96-08-06
Xiao Hui Jiang BRD
 Director/Board Member 69 21-09-09
Ke Fu Zhou BRD
 Director/Board Member 58 21-09-09

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 406,800,000 128,041,861 ( 31.48 %) 0 31.48 %

Shareholders

NameEquities%Valuation
TONGHUA DONGBAO PHARMACEUTICAL CO., LTD.
16.03 %
65,200,114 16.03 % 559 M ¥
Ying Yang
8.486 %
34,519,317 8.486 % 296 M ¥
Li Sun
7.999 %
32,539,237 7.999 % 279 M ¥
Yong Yuan Xie
4.966 %
20,200,053 4.966 % 173 M ¥
Zhi Hua Cai
2.809 %
11,428,121 2.809 % 98 M ¥
Yunnan International Trust Co., Ltd.
2.721 %
11,069,300 2.721 % 95 M ¥
Shan Xian Zheng
2.212 %
9,000,030 2.212 % 77 M ¥
Tibet Trust Corp. Ltd.
2.025 %
8,237,500 2.025 % 71 M ¥
Da Cheng Fund Management Co., Ltd.
1.481 %
6,023,526 1.481 % 52 M ¥
GF Securities Asset Management (Guangdong) Co., Ltd.
1.320 %
5,371,000 1.320 % 46 M ¥

Company contact information

Xiamen Amoytop Biotech Co. Ltd.

No. 330 Wengjiao Road Xinyang Industry Zone of Haicang

361028, Xiamen

+

http://www.amoytop.com
address Xiamen Amoytop Biotech Co., Ltd.(688278)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per region

Ratings for Xiamen Amoytop Biotech Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
59.5 CNY
Average target price
89.2 CNY
Spread / Average Target
+49.92%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
XIAMEN AMOYTOP BIOTECH CO., LTD. Stock Xiamen Amoytop Biotech Co., Ltd.
+13.66% 3.63B
CSL LIMITED Stock CSL Limited
-2.68% 85.68B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+4.08% 41.4B
BIOGEN INC. Stock Biogen Inc.
-25.35% 28.22B
UCB Stock UCB
+54.31% 24.64B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-4.52% 16.98B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-42.09% 13.29B
INCYTE CORPORATION Stock Incyte Corporation
-17.77% 11.66B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-12.10% 11.65B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+0.75% 8.18B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 688278 Stock
  4. Company Xiamen Amoytop Biotech Co., Ltd.